Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a global pharmaceutical company, today announced th...
read more
Targeted drug for lung cancer approved for NHS use in England

Targeted drug for lung cancer approved for NHS use in England

In two decisions published today, the National Ins...
read more
Drug rediscovery protocol allows doctors to prescribe anticancer drugs outside of their approved use

Drug rediscovery protocol allows doctors to prescribe anticancer drugs outside of their approved use

A large team of researchers affiliated with instit...
read more
The FDA Just Approved a Ketamine-Like Nasal Spray for People With Treatment-Resistant Depression. Here's What That Means

The FDA Just Approved a Ketamine-Like Nasal Spray for People With Treatment-Resistant Depression. Here's What That Means

The new antidepressant approved yesterday by the F...
read more